Medical/Pharmaceuticals
CHUV, CERN and THERYQ join forces for a world first in cancer radiotherapy
LAUSANNE, Switzerland, and PEYNIER, France, Nov. 25, 2022 /PRNewswire/ -- The Centre Hospitalier Universitaire Vaudois (CHUV) inLausanne, Switzerland, the European Laboratory for Particle Physics (CERN) and THERYQ (ALCEN Group) have signed an agreement for the world-first development of a revolut...
2022-11-25 17:15
7671
Peijia Medical Limited and inQB8 Medical Technologies, LLC report Successful First-in-Human implantation of MonarQ Transcatheter Tricuspid Valve Replacement System
SUZHOU, China, Nov. 25, 2022 /PRNewswire/ -- inQB8 Medical Technologies, LLC (inQB8), in Partnership with Peijia Medical Limited (Peijia, (9996.HK)), announced today that it has successfully implanted the MonarQ Transcatheter Tricuspid Valve in a 75-year-old female suffering from severe torrentia...
2022-11-25 16:00
3500
Australian Scientists Honoured with the Grand Hamdan Award
DUBAI, UAE, Nov. 25, 2022 /PRNewswire/ -- The Award ceremony of the Sheikh Hamdan bin Rashid Al Maktoum Award for Medical Sciences, hosted in Dubai, took place on 23rd of November the Museum of the Future. The Award celebrated its 12th term (2021-2022) and 22nd year, in the presence of SheikhRas...
2022-11-25 10:39
4209
AstraZeneca Thailand Wins Two ACES Awards 2022: "Industry Champions of the Year" and "Community Initiative"
BANGKOK, Nov. 25, 2022 /PRNewswire/ -- AstraZeneca (Thailand) Co., Ltd., was
recently honoured with two accolades in the categories ofIndustry Champions of
the Year and Community Initiative at the Asia Corporate Excellence &
Sustainability Awards 2022(ACES Awards 2022).
2022-11-25 10:00
5202
XtalPi and CK Life Sciences to collaborate in AI-empowered tumour vaccine research and development, opening a new paradigm for scientific innovation
AI-driven drug research and development (R&D) is breaking new ground, providing faster and more effective treatment options for more patients worldwide HONG KONG and SHENZHEN, China, Nov. 25, 2022 /PRNewswire/ -- XtalPi announced today that they are embarking on a strategic collaboration with CK ...
2022-11-25 09:49
4105
Mabwell Announces the U.S. FDA approval of 9MW3011 (FIC) for IND
SHANGHAI, Nov. 24, 2022 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with the layout of whole industry chain, announced that its clinical trial application for 9MW3011 Injection used in patients with polycythemia vera was formally approved by the United States Food...
2022-11-24 21:00
5201
Female expat entrepreneur fundraising for a local charity in support of victims of domestic violence, says: "Don't be silent!"
SINGAPORE, Nov. 24, 2022 /PRNewswire/ -- Natalia Denisko who is also the founder of Denisko Arts organised an autumn fundraising art sale event of Singaporeanand European Artists in support of Care Corner Singapore. It took place in the iconic Maison Ikkoku onNovember 19, 2022. Guests attending t...
2022-11-24 13:01
3617
Vieworks exhibits at RSNA 2022 with its complete lineup of next generation x-ray flat panel detectors
ANYANG, South Korea, Nov. 24, 2022 /PRNewswire/ -- Vieworks, a leading digital
x-ray imaging solution provider based inSouth Korea, will be exhibiting its
complete lineup of DR flat panel detectors (FPD) and dynamic FPDs at RSNA 2022
(South Hall #1723) fromNovember 27th to November 30th.
2022-11-24 10:00
4347
Edenlux launches AI-based service "Otus Plus Eye Health Care Report"
SEOUL, South Korea, Nov. 24, 2022 /PRNewswire/ -- On November 24, Edenlux (CEO
Sy Park) announced that it will provide an artificial intelligence (AI) eye
health management report for the users of Otus Plus, its flagship product.
2022-11-24 08:00
4922
IonOpticks ushers in a new age of proteomics with Aurora Frontier
MELBOURNE, Australia, Nov. 24, 2022 /PRNewswire/ -- The field of proteomics is set to be revolutionised with the launch today of IonOpticks' Aurora Frontier that achieves more than 10,000 proteins per sample. This near-full proteome coverage, a depth previously considered unattainable, unlocks t...
2022-11-24 06:00
3900
The 13th China (Taizhou) International Medical Expo successfully held
TAIZHOU, China, Nov. 24, 2022 /PRNewswire/ -- From November 19 to 21, the 13th China (Taizhou) International Medical Expo was held in China Medical City (CMS). Themed "Healthy China Strategy Leading the Construction of Demonstration Zones", this year's expo held 23 special events including the CM...
2022-11-24 01:13
4219
AcuCort signs its first commercial agreement for the company's drug Zeqmelit™
LUND, Sweden, Nov. 24, 2022 /PRNewswire/ -- AcuCort AB (publ) (Spotlight Stock Market: ACUC) today announces that the company has signed an exclusive commercial agreement with the global biopharmaceutical company Kamada Ltd., (NASDAQ: KMDA; TASE: KMDA.TA). The agreement gives Kamada the exclusive...
2022-11-24 00:42
4166
AnchorDx Enrolls the First Patient For Its UriFind® Bladder Cancer Assay Clinical Trial in the U.S.
GUANGZHOU, China, Nov. 23, 2022 /PRNewswire/ -- AnchorDx, a world-leading developer of cancer early detection solutions, announced the first patient enrollment for the UriFind® bladder cancer assay clinical trial in the U.S., an over 1,000-patient multi-center, prospective testing of the assay in...
2022-11-23 22:00
4772
Gracell Biotechnologies to Participate in Two Upcoming Investor Conferences
SAN DIEGO, Calif., and SUZHOU and SHANGHAI, China, Nov. 23, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment o...
2022-11-23 21:00
4985
Ascletis Announces IND Approval of Oral 3CLpro Inhibitor ASC11 for COVID-19 by U.S. FDA
--The Phase I clinical trial will consist of 3 cohorts in healthy subjects, including single- and multiple-dose escalation studies and food effect study. The objective of Phase I trial is to find a right dose to move into the pivotal Phase II/III in COVID-19 patients --In antiviral cellular assa...
2022-11-23 19:43
5154
J INTS BIO, M.D Anderson Cancer Center joint development - oral HSP90 inhibitor 'JIN-001', presentation of preclinical assessment at 2022 SNO Annual Meeting
SEOUL, South Korea, Nov. 23, 2022 /PRNewswire/ -- J INTS BIO announced that the preclinical assessment of JIN-001 or MPT0B640, a novel, orally administered 2nd generation HSP90 (heat shock protein 90) inhibitor, was presented during the 2022 edition of the Society for Neuro-Oncology Conference, h...
2022-11-23 15:18
2534
Jiangsu Traditional Chinese Medicine International Exchange Conference kicked off in Nanjing
NANJING, China, Nov. 23, 2022 /PRNewswire/ -- On November 21st, the "Jiangsu Traditional Chinese Medicine International Exchange Conference" jointly sponsored by the Foreign Affairs Office of Jiangsu Provincial People's Government and Jiangsu Health Commission kicked off inNanjing. The theme of t...
2022-11-23 14:19
2879
Lunit Partners with CARPL.ai to Accelerate AI-Powered Medical Imaging Across Major Overseas Channels
* Lunit signed a global distribution agreement to provide its AI-based radiology solutions for clinical use via CARPL.ai's platform * The partnership will deliver Lunit INSIGHT CXR and Lunit INSIGHT MMG for commercial use in the U.S.,Australia, Brazil, India, and Singapore SEOUL, South Korea,...
2022-11-23 12:30
4431
Interplex Announces Stackable Multi-Row Board-to-Board Connector Products That Achieve Unprecedented Flexibility
Automotive-grade product offers a reliable, repeatable and versatile solution
that can be scaled up in line with specific customer requirements
SINGAPORE, Nov. 22, 2022 /PRNewswire/ -- Interplex,
2022-11-22 21:00
5379
Illuccix® Available on High Activity Gallium Generator Technology to Meet High Demand
INDIANAPOLIS, Nov. 22, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces Illuccix® (kit for the preparation of gallium Ga 68 gozetotide injection) with up to 50mCi for radiolabeling is available for use on 100mCi (millicurie) gallium generators, an ...
2022-11-22 20:00
3116
Week's Top Stories
Most Reposted
OceanaGold Reports Third Quarter 2026 Results
[Picked up by 1141 media titles]
2026-11-05 06:52Royal Bank of Canada announces agreement to acquire Yarra Capital Management
[Picked up by 1141 media titles]
2026-11-09 21:00Algolia Powers Orange with AI Agents for Billing Support: NYSE Content Update
[Picked up by 1121 media titles]
2026-11-06 22:06
Cision Report Reveals the Consumer Trends Hidden Between Search, Social, and AI
[Picked up by 1105 media titles]
2026-11-09 23:00
Overstory Launches Integrated AI Platform to Deliver First Living Model of Grid Risk
[Picked up by 1083 media titles]
2026-11-03 22:00Most Read
Home Companion Robot Mobo to Debut Globally and Open Pre-orders as AiMOGA Showcases Its Robot Family at the 2026 OMODA & JAECOO International User Summit
2026-11-07 13:49
26160
ZD Energy Unveils Overseas Smart Energy Solutions in Thailand, Leveraging Local Manufacturing and Scenario-Based Capabilities to Support the Country's Energy Transition
2026-11-06 22:12
15066
SILVERSEA MARKS HISTORIC OPENING OF THE CORMORANT AT 55 SOUTH, THE SOUTHERNMOST HOTEL ON EARTH, OFFERING A NEW GATEWAY TO ANTARCTICA
2026-11-07 01:05
14554
OceanaGold Reports Third Quarter 2026 Results
2026-11-05 06:52
14404